FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2607323786> ?p ?o ?g. }

• W2607323786 endingPage "92" @default.
• W2607323786 startingPage "86" @default.
• W2607323786 abstract "Osteoblasts, originating from mesenchymal cells, make the receptor activator of the nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG) in order to control differentiation of activated osteoclasts, originating from hematopoietic stem cells. When the RANKL binds to the RANK of the pre-osteoclasts or mature osteoclasts, bone resorption increases. On the contrary, when OPG binds to the RANK, bone resorption decreases. Denosumab (AMG 162), like OPG (a decoy receptor), binds to the RANKL, and reduces binding between the RANK and the RANKL resulting in inhibition of osteoclastogenesis and reduction of bone resorption. Bisphosphonates (BPs), which bind to the bone mineral and occupy the site of resorption performed by activated osteoclasts, are still the drugs of choice to prevent and treat osteoporosis. The merits of denosumab are reversibility targeting the RANKL, lack of adverse gastrointestinal events, improved adherence due to convenient biannual subcutaneous administration, and potential use with impaired renal function. The known adverse reactions are musculoskeletal pain, increased infections with adverse dermatologic reactions, osteonecrosis of the jaw, hypersensitivity reaction, and hypocalcemia. Treatment with 60 mg of denosumab reduces the bone resorption marker, serum type 1 C-telopeptide, by 3 days, with maximum reduction occurring by 1 month. The mean time to maximum denosumab concentration is 10 days with a mean half-life of 25.4 days. In conclusion, the convenient biannual subcutaneous administration of 60 mg of denosumab can be considered as a first-line treatment for osteoporosis in cases of low compliance with BPs due to gastrointestinal trouble and impaired renal function." @default.
• W2607323786 created "2017-04-28" @default.
• W2607323786 creator A5022480009 @default.
• W2607323786 creator A5042999832 @default.
• W2607323786 creator A5048597460 @default.
• W2607323786 creator A5049559399 @default.
• W2607323786 date "2017-04-30" @default.
• W2607323786 modified "2023-09-27" @default.
• W2607323786 title "Can denosumab be a substitute, competitor, or complement to bisphosphonates?" @default.
• W2607323786 cites W1424085260 @default.
• W2607323786 cites W1521321020 @default.
• W2607323786 cites W1621696727 @default.
• W2607323786 cites W1966063111 @default.
• W2607323786 cites W1970144926 @default.
• W2607323786 cites W1989880575 @default.
• W2607323786 cites W1997823019 @default.
• W2607323786 cites W2005533362 @default.
• W2607323786 cites W2006391321 @default.
• W2607323786 cites W2025672294 @default.
• W2607323786 cites W2040471162 @default.
• W2607323786 cites W2042827704 @default.
• W2607323786 cites W2044250052 @default.
• W2607323786 cites W2075442847 @default.
• W2607323786 cites W2097566614 @default.
• W2607323786 cites W2109333569 @default.
• W2607323786 cites W2118914286 @default.
• W2607323786 cites W2119890177 @default.
• W2607323786 cites W2124157902 @default.
• W2607323786 cites W2134793345 @default.
• W2607323786 cites W2139860898 @default.
• W2607323786 cites W2140421126 @default.
• W2607323786 cites W2152578289 @default.
• W2607323786 cites W2160005424 @default.
• W2607323786 cites W2167847171 @default.
• W2607323786 cites W2171709369 @default.
• W2607323786 cites W2416031109 @default.
• W2607323786 cites W2482202957 @default.
• W2607323786 cites W2514668442 @default.
• W2607323786 cites W2526042389 @default.
• W2607323786 cites W2555291842 @default.
• W2607323786 cites W2562510311 @default.
• W2607323786 cites W4231991879 @default.
• W2607323786 doi "https://doi.org/10.3344/kjp.2017.30.2.86" @default.
• W2607323786 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5392661" @default.
• W2607323786 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28416991" @default.
• W2607323786 hasPublicationYear "2017" @default.
• W2607323786 type Work @default.
• W2607323786 sameAs 2607323786 @default.
• W2607323786 citedByCount "13" @default.
• W2607323786 countsByYear W26073237862017 @default.
• W2607323786 countsByYear W26073237862018 @default.
• W2607323786 countsByYear W26073237862020 @default.
• W2607323786 countsByYear W26073237862021 @default.
• W2607323786 countsByYear W26073237862022 @default.
• W2607323786 countsByYear W26073237862023 @default.
• W2607323786 crossrefType "journal-article" @default.
• W2607323786 hasAuthorship W2607323786A5022480009 @default.
• W2607323786 hasAuthorship W2607323786A5042999832 @default.
• W2607323786 hasAuthorship W2607323786A5048597460 @default.
• W2607323786 hasAuthorship W2607323786A5049559399 @default.
• W2607323786 hasBestOaLocation W26073237861 @default.
• W2607323786 hasConcept C125870589 @default.
• W2607323786 hasConcept C126322002 @default.
• W2607323786 hasConcept C131075544 @default.
• W2607323786 hasConcept C134018914 @default.
• W2607323786 hasConcept C146562846 @default.
• W2607323786 hasConcept C160160445 @default.
• W2607323786 hasConcept C170033053 @default.
• W2607323786 hasConcept C170493617 @default.
• W2607323786 hasConcept C181199279 @default.
• W2607323786 hasConcept C185592680 @default.
• W2607323786 hasConcept C2776033226 @default.
• W2607323786 hasConcept C2776286101 @default.
• W2607323786 hasConcept C2776541429 @default.
• W2607323786 hasConcept C2779179475 @default.
• W2607323786 hasConcept C2779428903 @default.
• W2607323786 hasConcept C2780426850 @default.
• W2607323786 hasConcept C55493867 @default.
• W2607323786 hasConcept C673006 @default.
• W2607323786 hasConcept C71924100 @default.
• W2607323786 hasConcept C88045685 @default.
• W2607323786 hasConceptScore W2607323786C125870589 @default.
• W2607323786 hasConceptScore W2607323786C126322002 @default.
• W2607323786 hasConceptScore W2607323786C131075544 @default.
• W2607323786 hasConceptScore W2607323786C134018914 @default.
• W2607323786 hasConceptScore W2607323786C146562846 @default.
• W2607323786 hasConceptScore W2607323786C160160445 @default.
• W2607323786 hasConceptScore W2607323786C170033053 @default.
• W2607323786 hasConceptScore W2607323786C170493617 @default.
• W2607323786 hasConceptScore W2607323786C181199279 @default.
• W2607323786 hasConceptScore W2607323786C185592680 @default.
• W2607323786 hasConceptScore W2607323786C2776033226 @default.
• W2607323786 hasConceptScore W2607323786C2776286101 @default.
• W2607323786 hasConceptScore W2607323786C2776541429 @default.
• W2607323786 hasConceptScore W2607323786C2779179475 @default.
• W2607323786 hasConceptScore W2607323786C2779428903 @default.
• W2607323786 hasConceptScore W2607323786C2780426850 @default.
• W2607323786 hasConceptScore W2607323786C55493867 @default.

• next